Results 121 to 130 of about 63,989 (248)

Epidemiology of Cancer‐Associated Venous Thromboembolism Across the United States

open access: yesAmerican Journal of Hematology, Volume 101, Issue 5, Page 1005-1018, May 2026.
ABSTRACT Prior epidemiological studies on cancer‐associated venous thromboembolism (VTE) were limited by homogenous patient populations. We leverage Cosmos, a collaborative dataset of Epic electronic health record systems, to conduct an updated evaluation of cancer‐associated VTE in the United States (US).
Barbara D. Lam   +7 more
wiley   +1 more source

Rivaroxaban for the Treatment of Pulmonary Embolism [PDF]

open access: yes, 2013
With the advent of new oral anticoagulants (NOACs) for the treatment of deep-vein thrombosis (DVT) and/or pulmonary embolism (PE), a new era of oral anticoagulation for patients with venous thromboembolism (VTE) has begun.
Peter Verhamme, Thomas Vanassche
core   +1 more source

Use of andexanet alfa: A British Society for Haematology position statement

open access: yes
British Journal of Haematology, EarlyView.
Richard J. Buka   +10 more
wiley   +1 more source

DOAC Score Versus HAS‐BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants

open access: yesClinical Cardiology, Volume 49, Issue 5, May 2026.
ABSTRACT Background The comparative performance of the DOAC score versus established bleeding risk scores in patients with atrial fibrillation (AF) receiving direct oral anticoagulants (DOACs) remains uncertain. This meta‐analysis evaluated the predictive ability of the DOAC score compared with HAS‐BLED and ORBIT.
Yanfei Guo, Wengen Zhu, Qunfeng Ren
wiley   +1 more source

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban

open access: yesPharmaceutics, 2019
Concomitant use of rivaroxaban with non-dihydropyridine calcium channel blockers (non-DHPs) might lead to an increase of systemic rivaroxaban exposure and anticoagulant effects in relation to the inhibition of metabolic enzymes and/or transporters by non-
Minsoo Kim   +5 more
doaj   +1 more source

Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Crocus sativus L., commonly known as saffron, is a widely used spice with a rich history of culinary and medicinal applications. This systematic review aims to compile human data from studies on monopreparations of C. sativus, including stigma powder and other extracts, to evaluate their safety.
Fatemeh Sadat Hasheminasab   +3 more
wiley   +1 more source

Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.

open access: yesJournal of the American Society of Nephrology, 2019
BACKGROUND Vitamin K antagonists (VKAs), although commonly used to reduce thromboembolic risk in atrial fibrillation, have been incriminated as probable cause of accelerated vascular calcification (VC) in patients on hemodialysis.
A. D. De Vriese   +9 more
semanticscholar   +1 more source

Colorectal Cancer Complicated by Pulmonary Embolism and Potential Takotsubo Cardiomyopathy in a Person With Cystic Fibrosis: Diagnostic and Management Considerations

open access: yesRespirology Case Reports, Volume 14, Issue 5, May 2026.
We describe a complex case of pulmonary embolism and dilated cardiomyopathy in a person with cystic fibrosis. These late complications occurred following laparoscopic left hemicolectomy for colonic adenocarcinoma. This case highlights the complexities of evaluating breathlessness in severe lung disease, and the management challenges that arise as life ...
Laura Frederiksen   +3 more
wiley   +1 more source

The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin [PDF]

open access: yes, 2011
Background Current treatments for the prevention of thromboembolism include heparin and low-molecular weight heparins (LMWHs). A number of studies have suggested that long term administration of these drugs may adversely affect osteoblasts ...
Gandhi N Solayar   +2 more
core   +1 more source

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

open access: yesClinical Pharmacology: Advances and Applications, 2014
Charles Frost,1 Yan Song,1 Yu Chen Barrett,1 Jessie Wang,2 Janice Pursley,3 Rebecca A Boyd,4 Frank LaCreta1 1Exploratory Clinical and Translational Research, 2Exploratory Development Global Biometric Sciences, 3Analytical and Bioanalytical Development ...
Frost C   +6 more
doaj  

Home - About - Disclaimer - Privacy